UB-312

· United Neuroscience Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for UB-312, covering 2025-03-06 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: UB-312 in Patients With Synucleinopathies [Phase 1]